2003•The Journal of the American Board of Family MedicineOpen access

Recombinant Factor VIIa for Uncontrolled Bleeding in 2 Different Cases of Coagulopathy

J. Islam, Salman Azhar, J. B. Alperin, Imran Syed

Open full text 2 citations

Abstract

Coagulation factor VIIa (Recombinant) (rF.VIIa; NovoSeven) was approved for use in the United States by the Food and Drug Administration in March 1999 for the treatment of bleeding episodes in patients with hemophilia A or B with inhibitors to factor VIII or factor IX. Off-label use of rF.VIIa to

Open-access reader

About this research paper

What this paper is about

Coagulation factor VIIa (Recombinant) (rF.VIIa; NovoSeven) was approved for use in the United States by the Food and Drug Administration in March 1999 for the treatment of bleeding episodes in patients with hemophilia A or B with inhibitors to factor VIII or factor IX. Off-label use of rF.VIIa to

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Coagulation factor VIIa (Recombinant) (rF.VIIa; NovoSeven) was approved for use in the United States by the Food and Drug Administration in March 1999 for the treatment of bleeding episodes in patients with hemophilia A or B with inhibitors to factor VIII or factor IX. Off-label use of rF.VIIa to

Key concepts: Medicine, Recombinant factor VIIa, Coagulopathy, Factor VIIa, Food and drug administration, Coagulation, Factor VII, Recombinant DNA

Related papers

Back to paper searchBrowse research topicsOriginal source
Recombinant Factor VIIa for Uncontrolled Bleeding in 2 Different Cases of Coagulopathy — Research Paper | ScholarLens